![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 29, 26185-26193, July 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,From the Wellcome Centre for Molecular Parasitology, University of Glasgow, Anderson College, 56 Dumbarton Road, Glasgow G11 6NU, Scotland, United Kingdom
Received for publication, April 4, 2002
| |
ABSTRACT |
|---|
|
|
|---|
We demonstrate, by gene deletion analysis, that
Mre11 has a critical role in maintaining genomic integrity in
Trypanosoma brucei. mre11 Multiple functions have been ascribed to the tripartite Mre11
complex (1), including roles in DNA repair, cell cycle control, meiosis, and telomere maintenance. The core of the complex consists of
Mre11 and Rad50, both of which remain highly conserved across all
kingdoms (2-5), whereas the third component, Xrs2 (Nbs1), exists only
in eukaryotes and is quite divergent between species (6). It appears
that Mre11 is the central protein in this complex, since it can
interact with either of the other two proteins, whereas Rad50 requires
Mre11 for Xrs2 binding (7).
DNA double strand breaks
(DSBs)1 arise frequently
during replication (8-10) and can be induced by ionizing radiation,
mutagenic chemicals, or free radicals generated during cell metabolism
(11). Additionally, DSBs occur as natural intermediates during specific processes such as mating type switching in Saccharomyces
cerevisiae (12) and mammalian V(D)J recombination (13). DSB repair
is mediated by two independent pathways, non-homologous end-joining and
homologous recombination (HR), both of which mediate repair via the
Mre11 complex in S. cerevisiae (14-16). Inactivation of the
Mre11 complex results in the accumulation of DSBs in a number of
organisms (2, 10, 17, 18), and these DNA lesions cause lethality in
vertebrate mre11 The involvement of the Mre11 complex (to which we refer as the M/R
complex) in DSB repair operates at several levels, including nucleolytic processing of the break, acting as a DNA damage signal sensor/transducer, and determining cell cycle checkpoints. Mre11 is
involved in nucleolytic processing of DNA ends at DSBs during HR and
possibly non-homologous end-joining (1-5, 23), whereas a DNA binding
activity of the complex may facilitate strand exchange and end-joining
reactions (1, 11, 23, 24). The M/R complex forms foci at sites of DNA
damage (7, 25-28). These DNA damage detection and repair functions are
essential for maintaining genomic integrity (11, 28-30), and M/R
complex mutants display an increase in spontaneous gross chromosomal
rearrangements (GCRs) (18, 30, 31), notably in the human cancer
predisposition syndromes ataxia telangiectasia-like disorder and
Nijmegen breakage syndrome. These conditions, which are initiated by
mutation in the MRE11 gene (32) and the NBS1
(XRS2) gene (33), respectively, also result in
hypersensitivity to ionizing radiation. The complex also plays a role
in chromosome integrity at telomeres, such that deletion of any one of
its three proteins results in telomere shortening in yeast (15, 34,
35). In this role, the MRE11 complex interacts epistatically with
telomerase but synergistically with the Ku proteins (35, 36).
Homologous recombination is important in the survival of African
trypanosomes, unicellular parasites that diverged early during eukaryotic evolution and display peculiarities in their gene expression and metabolism. Bloodstream form trypanosomes are protected by a
variant surface glycoprotein (VSG) coat, which masks the underlying invariant surface antigens and inhibits the nonspecific immune mechanisms of the mammalian host. Although only one VSG species is
present on the cell surface at any particular time, the parasite evades
destruction by periodically switching to another VSG, using a process
known as antigenic variation (for recent reviews see Refs. 37-41).
Each trypanosome potentially can produce probably hundreds of distinct
surface coats (42, 43). The majority of antigenic variation is driven
by HR, where silent VSG genes are duplicated and transposed
into a transcriptionally active telomeric locus (the bloodstream
expression site (BES)). The importance of HR in this switching is shown
by the central involvement of Rad51, a major HR enzyme (44).
Given the involvement of Mre11 in DNA repair and recombination, as well
as in telomere biology, it is important to understand how the protein
acts in trypanosome antigenic variation, a process involving
recombination and transcriptional regulation conducted largely at
telomeres. Here we show that mre11 Trypanosome Strains, Transformation, and VSG
Switching--
Monomorphic bloodstream form T. brucei 221a
trypanosomes of the strain 3174.2 (44, 45), a derivative of strain
Lister 427 (46), were grown in vitro at 37 °C in HMI-9
medium (47), and transformations were performed by electroporation as
described previously (44). Pleomorphic bloodstream form trypanosomes of the ILTat 1.2 line (strain EATRO 795) were cultured in HMI-9 medium + 1.1% methylcellulose, and transformants were selected by plating 6 × 106 transformed cells in 36 ml of medium over a
24-well dish. VSG switching frequencies and mechanisms were measured in
the marked strain 3174.2 as described (44, 45).
Generation and Analysis of mre11
Drug resistance integrations were examined by Southern blot analysis.
Genomic DNA was digested with EcoRI and separated on a 0.7%
agarose gel, blotted onto nylon membrane (Hybond XL, Amersham Biosciences), hybridized with Re-expression of Mre11 in the Null Mutant Trypanosomes--
A
re-expression cassette, tub::MRE11-BLE,
was designed to introduce MRE11 into the TUBULIN
array. The entire MRE11 ORF (2292 bp) was contained within a
3300-bp product amplified from genomic DNA by PCR with Herculase
polymerase (Stratagene) using the following primers: MRE115',
5'-tctttgcgccaatttttctcgg-3', and MRE113',
5'-aaataagggtggtggtaatgcg-3'. The product was cloned in pBluescript
upstream of a 400-bp bleomycin phosphotransferase ORF, which possessed
a 400-bp 5'-processing region derived from the ACTIN
intergenic sequence. The whole construct was encompassed by targeting
flanks specific to the TUBULIN intergenic region, as in the
construct tub::RAD51-BSR (44).
Following digestion with NotI and PspOMI, the
construct was transformed into the null mutant line
mre11 Cell Cycle Analysis--
The DNA content of the
mre11 GCR Examination--
MRE11+/+,
MRE11+/ Assessing Mutagen Sensitivity--
Cells were grown to a density
of ~5 × 105-2 × 106
cells·ml Integration Efficiency--
The efficiency of integration of the
construct tubBLEtub, which targets to the TUBULIN
array, replacing an Identification of T. brucei MRE11 and Generation of Knockout
Mutants--
BLAST searching of the NCBI data base revealed a
2292-bp MRE11 gene homologue on chromosome II of
T. brucei. Fig. 1
depicts an alignment of the predicted polypeptide with four eukaryotic Mre11 sequences (accession number of MRE11 from T. brucei EATRO 795, AJ426461). The first two-thirds show
considerable homology, with the T. brucei sequence including
the five highly conserved phosphodiesterase motifs associated with
nuclease activity and observed in both eukaryotic and prokaryotic Mre11
homologues (2-5, 48, 49). In contrast, the C terminus, responsible for
DNA binding, is not well conserved between species (3). Southern mapping indicated that this putative MRE11 gene is unique
within the T. brucei genome (data not shown).
Trypanosome mre11 mre11
To elucidate the cause of the mre11 mre11
To understand how these GCRs were occurring, we determined the genomic
distribution of two housekeeping genes, located ~0.55 Mb apart on
chromosome I. The three phosphoglycerate kinase (PGK) genes
are arranged in tandem between 190,189 and 192,583 bp on the
chromosome, whereas the second marker gene, glucose-6-phosphate isomerase (GPI), is unique and resides at 742,127 to 743,950 bp. Southern analysis with a PGK probe (Fig. 4)
revealed two bands of constant size across the wild type and
MRE11+/
We next investigated the effect of GCR on the VSG 121 family, which in 3174.2 cells consists of 5 genes in separate loci. Fig. 5 demonstrates a Southern blot of
XmnI-digested genomic DNA from the same wild type,
MRE11+/
In summary, it appears that the GCRs arising in
mre11
Unlike with T. brucei KU70 or KU80
(69), mutation of MRE11 appears not to result in shorter
telomeres (Fig. 5). Telomere length was also investigated at the
VSG 221 active BES, but again no significant shortening was
observed in clones derived after 115 or 550 cell generations (data not
shown). Genomic DNA was also prepared from trypanosome clones that had
grown in culture for 550 generations but had not been re-cloned. This
displayed a telomere smear, which was longer (extending to shorter
fragments) in mre11 Effects of Mre11 Inactivation on Mutagen Sensitivity and
Recombination--
Previously, we have demonstrated (44) that
T. brucei rad51
We next determined the tubBLEtub integration sites in the
wild type, MRE11+/
Finally, we investigated whether Mre11 absence from monomorphic 427 trypanosomes affects VSG gene switching. VSG
switching can be achieved by several different mechanisms, including
transcriptional switching between BESs and gene duplication into the
active BES, and in the 427 strain used here the switch rate occurs at
background level (1 × 10 Our findings add to the emerging picture that T. brucei
generally has the recombination and repair pathways observed in other eukaryotes but with some large differences. The Rad51 pathway dominates, and the role of other pathways appears to be modified, perhaps in relation to special requirements of the trypanosome genome.
The phenotype of the trypanosome mre11 The difference in nature of GCR when compared with budding yeast may be
related to our unexpected finding of lack of sensitivity of the null
mutant to the DNA damage-inducing agent MMS. Usually, inactivation of
Mre11 leads to increased sensitivity to MMS (3, 7, 20, 22, 53),
although this is not always the case when the NBS1 component of the
human M/R complex is mutated (54). Nonetheless, the sensitivity of the
trypanosome null mutant to phleomycin and its altered integration
patterns do show that Mre11 is involved in repair and recombination.
The lack of MMS phenotype agrees with our finding that Mre11 has no
detectable involvement in VSG switching, which is mediated
by Rad51, the null mutant of which is MMS-sensitive (44). In other
organisms, the exact role of the M/R complex in the various processes
where it is featured is unclear. Although its nuclease activities are
often thought to be essential for generating 3'-overhangs that initiate
Rad51-mediated HR (1-5, 23), there is evidence that it plays another
role, bridging the two ends in the DSB (1, 11, 23, 24, 55, 56). Our
data from the mre11 Even though it is in direct contrast with what happens in S. cerevisiae (15, 34, 35, 59), the absence of a telomere phenotype
in trypanosome mre11 The lack of involvement of Mre11 in VSG switching might be
indicative of a greater than usual demarcation between DNA repair and
recombination pathways in T. brucei. VSG gene
switching, most of which is driven by recombination at a high rate,
involves a flow of VSG duplications toward telomeres. In
fact, it appears that most, if not all, the telomeres of the megabase
trypanosome chromosomes have been set aside to harbor VSG
transcription units (61). For proteins such as the M/R complex and Ku,
clear functional distinctions between their multifarious roles in
telomere function and in recombination might be necessary. It is
interesting, therefore, that we have found that neither the M/R complex
nor Ku (69) has a detectable role in VSG switching, at least
in the background-switching strain examined. This is in contrast to the
important role played by Rad51 (44). Perhaps a novel pathway of
recombination, or a modification of a general damage repair pathway,
has evolved to enable high frequency switching. Indeed, modification of
general pathways of recombination-based repair may explain the
limitation of individual GCRs to the same chromosome in
mre11
/
null
mutant strains exhibited retarded growth but no delay or disruption of
cell cycle progression. They showed also a weak hyporecombination
phenotype and the accumulation of gross chromosomal rearrangements,
which did not involve sequence translocation, telomere loss, or
formation of new telomeres. The trypanosome mre11
/
strains were hypersensitive to
phleomycin, a mutagen causing DNA double strand breaks (DSBs) but, in
contrast to mre11
/
null mutants in other
organisms and T. brucei rad51
/
null mutants, displayed no hypersensitivity to methyl methanesulfonate, which causes point mutations and DSBs. Mre11 therefore is important for
the repair of chromosomal damage and DSBs in trypanosomes, although in
this organism the intersection of repair pathways appears to differ
from that in other organisms. Mre11 inactivation appears not to affect
VSG gene switching during antigenic variation of a
laboratory strain, which is perhaps surprising given the importance of
homologous recombination during this process.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
mutants (10, 17-19). DSB
repair defects also occur in mre11
/
or
rad50
/
mutants, as manifest by their extreme
sensitivity to ionizing radiation and chemical mutagens causing DSBs,
and they are sensitive also to the mutagen methyl methanesulfonate
(MMS), which causes point mutations and DSBs (2, 3, 7, 10, 18,
20-22).
/
null
mutant strains display significant growth retardation, resulting from
decreased cell viability. The strains showed no change in VSG gene switching or in telomere length but did display
hypersensitivity to DNA damage and developed GCRs. Our work
demonstrates the significance of Mre11 in maintaining integrity of the
Trypanosoma brucei genome, and the absence of a detectable
role in VSG switching implies that DSBs either are not
involved or are processed independently of Mre11 in this process.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
Null Mutant
Lines--
The entire MRE11 ORF was substituted with
cassettes for puromycin N-acetyltransferase (puromycin
resistance) or blasticidin S deaminase (blasticidin resistance)
encompassed by flanks specific to the MRE11 locus. These
cassettes, derived from pTBT and pTPT (gifts of M. Cross and P. Borst,
the Netherlands Cancer Institute), were used over two successive rounds
of transformation to replace both alleles of the gene. Targeting flanks
were amplified from genomic DNA by PCR using Pfu DNA
polymerase (Stratagene). 5' flank primers:
5'-gcggaattcccctcgatagggtgaagggatgtg-3'
(EcoRI), and 5'-ccgaagcttgttaacgccgttaagacagatcaagatgagg-3'
(HindIII/HpaI). 3' flank primers:
5'-gcgaagcttccatgggtgtgtgtgttttttttttttaatttgtac-3' (HindIII/NcoI), and
5'-ccgctcgaggcaacaaaagaaactccctggggcgc-3' (XhoI). Prior to transformation of T. brucei, the
constructs were digested with NotI and PspOMI.
Transformants were selected with 5 µg·ml
1 blasticidin
or 1 µg·ml
1 puromycin.
-32P-radiolabeled DNA
specific to the MRE11 5'-targeting flank, and washed to high
stringency (0.1× SSC, 0.1% SDS at 65 °C).
/
2 and selected by plating
2 × 107 transformed cells in 36 ml of medium
containing 2.0 µg·ml
1 bleomycin (Invitrogen), over a
24-well dish. Successful integrations were identified by Southern analysis.
/
null mutant lines was examined by
fluorescence-activated cell sorting (FACS), supported by fluorescence microscopy. For FACS analysis, ~6 × 106 mid-log
phase cells were washed in phosphate-buffered saline (PBS) and fixed in
70% methanol/PBS. The trypanosomes were then stored at 4 °C for at
least 1 h, before being washed again in PBS and resuspended in PBS
supplemented with 10 µg·ml
1 propidium iodide and 10 µg·ml
1 RNase A. After 45 min at 37 °C, 1 × 104 cells were counted by FACS (FACSCalibur; BD PharMingen)
using the CellQuest analysis software (BD PharMingen). For fluorescence microscopy, mid-log phase cells were washed in PBS, spotted onto a
glass slide, fixed overnight in 100% methanol at
20 °C, and air-dried. Slides were then stained with 1 ng·µl
1
4,6-diamidino-2-phenylindole in PBS for 30 min and then washed in PBS.
Slides were mounted with PBS, 50% glycerol, 2.5%
diazabicyclo[2,2,2]octane. Approximately 400 cells were counted for
each sample examined.
, and mre11
/
trypanosome clones were derived by plating cells over a 96-well culture
dish at 1 cell·well
1. These populations were then
passaged in culture for ~550 generations and were re-cloned. Genomic
plugs were prepared by immobilizing live trypanosomes (5 × 107 cells in 100-µl plugs of 0.7% low melting point
agarose) and lysing them in NDS buffer, pH 9 (0.5 M EDTA,
10 mM Tris·HCl, pH 9, 1% SDS) , with 1 mg of proteinase
K·ml
1 at 56 °C for 48 h; the plugs were washed
at least three times in 1 ml of 1× TB(0.1)E electrophoresis buffer at
room temperature before gel separation. Chromosome-size DNA was
separated on the CHEF-DR III system (Bio-Rad), using one-half of a
genomic plug per lane in a 1.2% agarose gel, in 0.089 M
Tris borate, 0.1 mM EDTA (TB(0.1)E) at 85 V, 1400- to 700-s
pulse time, for 144 h at 15 °C.
1 and then diluted to 5 cells·ml
1 in HMI-9 medium supplemented with MMS (Sigma)
or 50 cells·ml
1 for phleomycin (Cayla). Each mutagen
was titrated against wild type trypanosomes to determine the sublethal
range. To assess the effect on growth, the diluted cells were spread
over a 96-well culture plate to give a final distribution of 1 trypanosome·well
1. After ~20 generations (6-7 days),
the wells were scored for the presence or absence of growth.
-tubulin gene and conferring bleomycin
resistance, was measured by plating 2 × 107
transformed cells in 36 ml of medium containing 2.0 µg·ml
1 bleomycin (Invitrogen) over a 24-well dish and
estimating integration frequency (= number of positive wells
(clones)/2 × 107). The tubBLEtub construct
could also integrate into TUBULIN sequence present at the
modified BES (flanking the hygromycin resistance cassette (45)) or
transgenic MRE11 locus (flanking the puromycin or
blasticidin resistance cassettes). Integration into these other loci
resulted in the loss of the hygromycin, puromycin, or blasticidin genes, respectively, events that were confirmed by performing PCR for
the appropriate resistance gene.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (85K):
[in a new window]
Fig. 1.
An alignment of T. brucei
Mre11 with homologues from other eukaryotes. The predicted
amino acid sequence of T. brucei Mre11 was aligned with
Mre11 from budding yeast (S. cerevisiae), Xenopus
(X. laevis), human (H. sapiens) and
Arabidopsis (A. thaliana). Residues identical
between three or more sequences are highlighted in black,
and conserved substitutions are in gray. Numbers
to the left of the sequence correspond to the amino acid
position at the start of each line. The solid bars above the
sequence depict five highly conserved phosphodiesterase motifs
(I-V).
/
null mutant strains were
created by substituting the entire ORF with cassettes for puromycin
N-acetyltransferase (puromycin resistance) or blasticidin S
deaminase (blasticidin resistance). These two drug resistance
cassettes, cloned between MRE11 flanking sequence, enabled
replacement of both alleles of the MRE11 gene via two
independent rounds of electroporation. Southern blot analysis confirmed
gene replacement (data not shown). Null mutant clones were derived by
this approach in both monomorphic (3174.2 transgenic marked strain, as
described previously (45)) and pleiomorphic (EATRO 795, ILTat 1.2)
bloodstream form trypanosomes.
/
Cells Exhibit Marked Growth
Retardation--
The proliferative dynamics of the
mre11
/
cells were analyzed immediately after
their derivation, using growth curves and cell cycle analysis. Fig.
2A depicts in vitro
growth curves of MRE11 wild type monomorphic bloodstream
cells and two independently generated MRE11+/
and mre11
/
cell lines, the latter of which
were derived directly from the heterozygous mutant lines under
analysis. The wild type and heterozygous cell lines displayed the same
growth rates, with an average population doubling time, during
exponential growth, of ~6.25 h. In contrast, the two independent null
mutant lines had a longer doubling time, on average about 8.5 h (a
36% increase in cell generation time relative to wild type or
MRE11+/
). This is similar to the growth
retardation in T. brucei rad51
/
mutant lines (44). In addition, and again consistent with
rad51
/
strains, the
mre11
/
lines reached slightly lower maximal
density in culture compared with the wild type or heterozygous cell
lines. Reintroduction of intact MRE11 into the tubulin locus
restored the wild type growth rate and maximal population density (Fig.
2A), confirming that the absence of Mre11 protein had caused
the growth defect. Growth of the bloodstream form
mre11
/
mutant cells of the pleomorphic cell
line ILTat 1.2 was also retarded (Fig. 2B). This pleomorphic
trypanosome strain grows to a lower maximal density than the 3174.2 line, but the average maximal density was similar for the
MRE11+/
and mre11
/
clones. Non-proliferative stumpy bloodstream form trypanosomes were
observed in both the MRE11+/
heterozygous and
homozygous mutant lines when the ILTat 1.2 populations grew to high
cell density, indicating that Mre11 absence does not impair trypanosome
differentiation from the long slender form to the short stumpy
form.

View larger version (19K):
[in a new window]
Fig. 2.
Growth dynamics of T. brucei
mre11-/- null mutant
clones. In the monomorphic strain 3174.2, in vitro
growth of wild type (MRE11+/+), heterozygote
(MRE11+/
), null mutant
(mre11
/
), and Mre11 re-expressor
(MRE11
/
/+) clones were compared by measuring
cell densities at the given times. MRE11+/
and
mre11
/
clones were compared in the
pleiomorphic ILTat 1.2 line. Standard deviations are indicated.
/
growth
defect, we next examined cell cycle progression in the 3174.2 wild
type, MRE11+/
, and
mre11
/
cells by FACS analysis and by
morphological examination of methanol-fixed trypanosomes using
fluorescence microscopy. We could not detect any delay or interruption
to the progression of mre11
/
trypanosomes
through the cell cycle (Fig. 3 and Table
I), suggesting that the impaired growth
most likely is due to increased cell mortality in the population.

View larger version (22K):
[in a new window]
Fig. 3.
Analysis of the effect of MRE11 inactivation
on cell cycle progression. FACS analysis of wild type (+/+)
T. brucei compared with two MRE11+/
heterozygote clones and two mre11
/
null
mutant clones. y axis, cell numbers; x axis,
relative DNA content on the basis of staining with propidium iodide.
The left peak represents cells with a DNA content of 2n,
whereas the right peak depicts cells at 4n.
Cell cycle distribution of different lines
/
cells were stained
with 2,4-diamidino-2-phenylindole and examined by fluorescence
microscopy. The number of nuclei (n) and kinetoplasts (k) per cell were
counted for approximately 400 mutant and wild type trypanosomes.
/
Null Mutant Cells Accumulate Gross
Chromosomal Rearrangements--
To determine possible causes of the
growth phenotype in mre11
/
cells, we studied
their molecular karyotype after prolonged growth. Wild type cells and
the two independent T. brucei 3174.2 MRE11+/
and mre11
/
lines were cloned, grown in vitro for ~550 generations,
and re-cloned, and genomic DNA was prepared (19 subclones in total: 3 wild type, 3 from each independent MRE11+/
,
and 5 from each independent mre11
/
). Pulsed
field gel (PFG) electrophoresis, utilizing conditions that resulted in
a broad chromosomal separation, demonstrated the occurrence of gross
chromosomal rearrangements (Fig. 4). It is apparent, even from the ethidium bromide-stained gels, that the
karyotypes of the wild type (lanes 1-3) and
MRE11+/
mutant clones (lanes 4-6
and 12-14) are indistinguishable from each other. This
chromosome pattern was consistent with PFG separations of DNA from 427 wild type cells (the progenitor of 3174.2) (50), indicating that no
visible gross chromosomal changes had occurred during the extensive
passaging period. In contrast, the subclones from the two independent
mre11
/
mutant lines displayed a high degree
of chromosome rearrangement (lanes 6-11 and
15-19). Only one mre11
/
mutant
subclone (lane 15) demonstrated any resemblance to the wild
type karotype, whereas all others appeared to have accumulated chromosomes in the <1-Mb to 1.9-Mb range, perhaps coincident with the
apparent loss of many of their larger chromosomes.

View larger version (94K):
[in a new window]
Fig. 4.
Gross chromosomal rearrangements in
mre11-/- mutants.
The upper and lower leftmost panels show ethidium
bromide-stained PFG electrophoretic separation of intact genomic DNA
from 3174.2 wild type (+/+), MRE11 heterozygotic (+/
), and
mre11 null mutant (
/
) T. brucei clones
(1 and 2 represent the two independent
transformant lines the clones are derived from after growth in
vitro for 550 generations). The three Southern blots show the same
PFGs probed sequentially with phosphoglycerate kinase (PGK),
glucose-6-phosphate isomerase (GPI), and VSG
221. Lanes 1-3, wild type clones; lanes
4-6, MRE11+/
1 clone; lanes
7-11, mre11
/
1 clone; lanes
12-14, MRE11+/
2 clones; lanes
15-19, mre11
/
2 clones.
lanes, representing the two alleles of
the locus. This demonstrates that the two homologues of chromosome I
are very different in size, at ~1.8 and 3.5 Mb, as shown previously
for 427 (50). In contrast, for the mre11
/
trypanosomes, at least 7 and possibly all 10 of the mutant clones exhibited significant reduction in the size of the smaller chromosome I
homologue, whereas 8 of the mutant clones displayed reduction in the
larger homologue; between 5 and 8 of the clones had reduction of both
chromosomes. Additionally, it appeared that 3 of the mutant clones had
lost one allele of the PGK locus (Fig. 4, lanes
8, 15, and 16). The one mutant clone that resembled the
wild type karyotype upon ethidium bromide staining (lane 15)
clearly displayed GCRs when probed for PGK. With the
exception of one mutant subclone, an identical hybridization pattern
was generated when the blots were stripped and re-probed with
GPI (Fig. 4), indicating that linkage of the two
markers was retained in 9 of the 10 mutant clones. The one discrepant
clone (lane 9) had lost one GPI allele, but had
retained both PGK alleles. Finally, the blots were stripped again and reprobed with DNA specific to VSG 221 (Fig.
4), which is the telomeric VSG in the active
bloodstream expression site located on chromosome VI (50).
Hybridization of this haploid gene revealed a significant reduction in
length of chromosome VI in 8 of the 10 mutant clones, but in none of
the wild type or heterozygous clones.
, and mre11
/
clones that were used in the PFG analysis. Five bands were observed in
all the wild type and MRE11+/
lanes (Fig. 5,
lanes 1-9); four of these are chromosome-internal genes, of
constant size, whereas the largest is the telomeric copy, lying in an
inactive BES, and for which differences in telomere tract length result
in size variation of the fragment. Five of the nine
mre11
/
clones examined had lost one internal
VSG 121 gene copy (Fig. 5, Ii in lanes
16 and 17, and Iii in lanes 10, 12, and 13), indicating that the GCRs can result in the
loss of non-essential genetic material. Notably, the telomeric gene
copy was never lost.

View larger version (84K):
[in a new window]
Fig. 5.
VSG 121 gene deletions resulting
from MRE11 inactivation. Genomic DNA from 3174.2 wild
type (+/+), MRE11+/
, and
mre11
/
clones was digested with
XmnI, separated in 0.7% agarose, and Southern-blotted. The
filter was probed with DNA specific to the VSG 121 ORF. One
telomeric (TEL) and four internal (Ii, Iii, Iiii,
and Iiv) gene copies are shown. Lanes 1-3, wild
type clones; lanes 4-6, MRE11+/
heterozygote 2 clones; lanes 7-9,
MRE11+/
heterozygote 1 clone; lanes
10-14, mre11
/
mutant 2 clones;
lanes 15-19, mre11
/
mutant 1 clone. * indicates mre11
/
clones in which an
internal gene copy has been lost.
/
trypanosomes are associated with
deletions within, and shortening of, chromosomes, and it is evident
from the PFG analysis that all of the megabase chromosomes can be
affected. Interestingly, the smaller intermediate and minichromosomal
repertoire of the parasites appeared largely unaffected in the null
mutant lines (data not shown). In contrast to studies in S. cerevisiae (31), there were no obvious cases of simple
translocations in mre11
/
cells, because
there were no increases in chromosome size.
/
cells than in
MRE11+/
or wild type cells (data not shown).
This observation implies that Mre11 plays a minor role in telomere
regulation in T. brucei.
/
mutant clones
display MMS sensitivity. Unexpectedly, we could not detect any MMS
sensitivity in the mre11
/
cells. A typical
dose-dependent inhibition of growth was observed in wild
type, MRE11+/
, and
mre11
/
cells grown in 0.0002, 0.0003, and
0.0004% MMS, but this was not more severe in
mre11
/
cells (data not shown). Confirmation
of this negative phenotype was achieved using a clone viability assay.
One trypanosome was plated into each well of a 96-well plate (at 0, 0.0002, 0.0003, or 0.0004% MMS), and after ~20 generations the
number of wells with growth was recorded. At 0% MMS, fewer
mre11
/
wells than
MRE11+/
or wild type wells showed growth (Fig.
6A), due to the reduction in
cell viability of the mutant clones. In the presence of mutagen, there
was no evidence for increased MMS sensitivity in the
mre11
/
parasites, allowing for the poor
growth of the mutant lines. As a positive control for MMS activity, we
tested simultaneously the growth of rad51
/
cells, and we observed the expected increased MMS sensitivity relative
to wild type (Fig. 6A). In contrast to the lack of
sensitivity to MMS, the homozygous mre11
/
mutant clones were hypersensitive to phleomycin (Fig. 6B).
These findings indicate a different from usual involvement of Mre11 in
HR, because Mre11 absence in a number of species causes MMS hypersensitivity. To investigate this further, we characterized the
effect of Mre11 absence on general HR by assaying the efficiency of
transformation by plasmid DNA. For this, we used the construct tubBLEtub, which normally should integrate a bleomycin
phosphotransferase cassette into the tubulin gene array using terminal
sequence homology to the tubulin intergenic sequences. In the wild type
and MRE11+/
lines, the transformation
efficiency was ~0.95 × 10
6 (Table
II), which is comparable with the
efficiencies observed in similar investigations using other drug
selection markers.2 The
mre11
/
cells displayed a reduced
tubBLEtub integration efficiency of ~0.25 × 10
6 although, considering that the viability of these
cells is around 50% that of wild type trypanosomes, the actual
transformation efficiency could be 0.5 × 10
6
(52.6% wild type integration efficiency).
rad51
/
mutant cells have an even poorer
transformation efficiency, on average 0.12-0.15 × 10
6 but in some instances as low as 0.03 × 10
6 (12-50% of mre11
/
targeting efficiency) (44)2 (Table II). These data indicate
that Mre11 plays a role in trypanosome HR but not as centrally as does
Rad51.

View larger version (33K):
[in a new window]
Fig. 6.
Effect of mutagens on growth of MRE11
mutants. MRE11 wild type (+/+),
MRE11+/
,
mre11
/
, and
rad51
/
trypanosomes were plated at 1 cell·well
1 in a 96-well plate at the mutagen
concentrations shown. A, MMS sensitivity. The number of
wells in the culture plates presenting growth after ~20
generations; figures are shown as means ± S.D. of wells
growing/96, from at least three independent experiments. Only
rad51
/
mutants were investigated at 0.0001%
MMS. B, phleomycin sensitivity. The data are means ± S.D. from two experiments each with two independent heterozygous clones
and with homozygous clones derived from them.
Genome integration efficiencies
and
mre11
/
cells were transformed with the construct
tubBLEtub, which targets a bleomycin phosphotransferase
cassette to the tubulin array. The integration efficiency was
calculated as the number of transformants arising from 2 × 107 cells.
, and
mre11
/
cells. In addition to the
TUBULIN array, the tubBLEtub construct could
integrate into the TUBULIN processing signals present in the
transgenic BES (particular to 3174.2 cells (45)) and into the TUBULIN flanks at the deleted MRE11 locus
alleles. Table III indicates that in wild
type and heterozygous cells, about 75% of the integrations occurred
into the tubulin gene array, and this high proportion may reflect the
greater number of TUBULIN copies compared with the other
targets. In contrast, the tubBLEtub construct appeared to
integrate equally into all of the three available homologous loci in
the null mutant cells. Similarly, rad51
/
trypanosomes demonstrate decreased targeting to the TUBULIN
array,2 perhaps indicating that Mre11 and Rad51 have some
common influence on trypanosome HR.
Integration loci of tubBLEtub
6 to 1 × 10
7 switch/cell/generation). The protocol used enables
determination of both switching rate and activation mechanisms, and
Table IV illustrates that we found no
differences in VSG switching between wild type,
MRE11+/
and mre11
/
lines.
VSG switching frequencies
, and
mre11
/
cells (ND, not determined; NA, not
applicable).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
null
mutant requires interpretation in the context of the M/R complex acting
in a number of interacting pathways. Prominent among the mutant
phenotype traits are the formation of GCRs and the reduced growth rate.
We believe these are related. The GCRs are not duplicative, because we
see only decreases in chromosome size, and do not result from loss of
terminal fragments, as is evident from the retention of the VSG
221 and VSG 121 telomeric genes in all clones. This is
in striking contrast to GCRs in S. cerevisiae
mre11
/
mutant cells, where 60% are duplicative
translocations and 30% are additions of new telomeres (31). It is
chromosome-internal sequence that is lost in trypanosome
rearrangements, and this happens perhaps randomly, as seen by the
disappearance of internal VSG 121 genes being only
occasional and GPI absence arising only once. This genome is
diploid, which can allow a high degree of loss of genetic material, as
long as essential genes are maintained in at least one copy. Although
the loss of even one complete chromosome copy would not be lethal, we
believe this is not happening at a high frequency in the
mre11
/
null mutant clones. A casual glance
at the ethidium bromide-stained pulsed field gels might suggest a
spectacular attrition, but more careful examination reveals otherwise,
as is evident also from Fig. 3 where the null mutant clones do not have
a noticeably reduced DNA content. The reason for GCR formation in the
mutants most likely is the same as in S. cerevisiae;
replication errors cause DSBs or gaps that are incorrectly repaired in
the absence of a functional M/R complex. This would be consistent with
the fact that GCRs do not arise as frequently in either T. brucei or S. cerevisiae
rad51
/
mutants (29).2 Why the
types of rearrangement that arise through
mre11
/
mutation are so different in the two
organisms is interesting and we believe due to specific requirements
for DNA repair and recombination in T. brucei (see below).
We can at least exclude trivial explanations for the lack of a short
telomere phenotype and the absence of translocations during GCRs in the
parasite. Telomerase activity and new telomere seeding have both been
detailed in T. brucei (51, 52), so there is no problem with
creating new chromosome ends following their deletion. Moreover,
antigenic variation involves the duplication of VSG genes
between chromosomes, so translocation is not only possible in T. brucei but is central to survival. The
mre11
/
growth phenotype we observed is
fairly major, yielding approximately a 36% increase in population
doubling time. Our cell cycle analysis has revealed no obvious
alteration in progression through the cell cycle, and we believe that
trypanosomes are dying as a consequence of the lethal event of deletion
of any essential gene for which the other allele has already been lost.
Alternatively, loss of one allele could prevent it being used as a
template for the repair of a DSB at the remaining allele.
/
null mutant point
against the trypanosome enzyme performing resection or bridging as a
prelude to Rad51-mediated HR repair of MMS damage or in VSG
switching, and other activities must account for these roles. This is
different from the active role trypanosome Mre11 plays in repair of
DSBs during replication and in promoting the integration of linear DNA
by HR. Here again, however, there are differences, because GCR
formation largely is Rad51-independent, whereas most HR integration is
Rad51-dependent. The similarities in relaxation in
stringency of insertion target site and reduction in transformation
efficiency, as observed in T. brucei
mre11
/
and rad51
/
null mutants (44), suggest these proteins act in a common pathway. It
may be that when the M/R complex is presented with two individual free
ends on a linear molecule (57), it performs exonucleolytically, in
conjunction with Rad51, rather than acting as a bridge. When Mre11 is
absent, shorter 3'-overhangs are created, driving the repair mechanism
toward a Rad51-insensitive pathway that operates on substrates with
shorter end homology,2 resulting in a wider range of
targets being available, as we observed for TUBULIN sequence
insertions. In the different situation of DSBs arising during
replication, the wild type repair pathway would involve Mre11 but not
Rad51. Here the main role of Mre11 may be as a sensor or signal of
damage, perhaps using its bridging activity, and coordinating repair of
the damage without RAD51, which relies upon long homology stretches
(30). Such a separation of function in MRE11 between
recognition/signaling and repair of damage has been suggested before
(28, 58). The distinct phenotypes of mre11
/
(and rad51
/
) mutants to the three situations
(MMS-induced damage, replication defects, and recombination of free
ends) is suggestive of differences between the trypanosome and other organisms.
/
null mutant cells is
not completely unexpected, in the sense that telomere maintenance and
recombinational events catalyzed by Mre11 differ in some ways.
Trypanosomes differ from the fungus in the structure of the chromosome
end, having a t-loop (60), so it is not necessarily the case that the
parasite uses the same proteins, such as Mre11, for telomere
maintenance. We have shown that Ku is important for telomere
maintenance in trypanosomes (69), and there may not be a need for
Mre11. It is not yet known whether, in any organism, Mre11 is important
for t-loop formation.
/
mutants and the lack of a role for
Mre11 in responding to MMS damage. A second genomic feature in the
trypanosome that may relate to this proposed demarcation between repair
and recombination is the abundance of repetitive sequence, estimated at
32% (62). Much of this is the satellite sequence that constitutes most
of the structure of the ~100 nuclear minichromosomes (63, 64), whereas other highly repetitive regions flank VSG genes (65, 66) and bloodstream VSG transcription units (61). The latter two repeat sequences are thought to have important roles in gene rearrangements and as insulators, respectively. The potential importance of the minichromosome repeats is seen in the fact that they
are remarkably stable in size, despite the repeats being identical in
sequence over most of their length (64). Even though Mre11 is thought
to help in the removal of secondary structures arising in some types of
repeat, thus preventing replication errors (67, 68), we find no such
problems arise in trypanosome minichromosomes when Mre11 is absent
(data not shown). It would not be surprising to find that maintenance
of such important repeated regions during trypanosome replication
depends on, besides a robust mismatch repair
system,3 a strict demarcation
between the different repair and recombination processes.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Sandra Terry for excellent technical assistance and Piet Borst and Mike Cross for the gift of plasmids.
| |
FOOTNOTES |
|---|
* This work was supported by the Wellcome Trust and the Royal Society.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: MRC Cancer Cell Unit, The Hutchison/MRC Centre,
Hills Road, Cambridge, CB2 2QH, UK.
§ Royal Society University Research Fellow.
¶ Wellcome Trust Principal Research Fellow. To whom correspondence should be addressed: Wellcome Centre for Molecular Parasitology, University of Glasgow, Anderson College, 56 Dumbarton Rd., Glasgow, G11 6NU, Scotland, UK. Tel.: 44-141-330-4875; Fax: 44-141-330-5422; E-mail: j.d.barry@bio.gla.ac.uk.
Published, JBC Papers in Press, May 13, 2002, DOI 10.1074/jbc.M203205200
2 C. Conway, C. Proudfoot, P. Burton, J. D. Barry, and R. McCulloch, submitted for publication.
3 J. Bell, J. D. Barry, and R. McCulloch, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: DSBs, double strand breaks; MMS, methyl methanesulfonate; PBS, phosphate-buffered saline; VSG, variant surface glycoprotein; HR, homologous recombination; GCRs, gross chromosomal rearrangements; BES, bloodstream expression site; ORF, open reading frame; FACS, fluorescence-activated cell sorting; PFG, pulsed field gel; Mb, megabase; PGK, phosphoglycerate kinase; GPI, glucose-6-phosphate isomerase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Haber, J. E. (1998) Cell 95, 583-586[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Bressan, D. A.,
Olivares, H. A.,
Nelms, B. E.,
and Petrini, J. H. J.
(1998)
Genetics
150,
591-600 |
| 3. | Furuse, M., Nagase, Y., Tsubouchi, H., Murakami-Murofushi, K., Shibata, T., and Ohta, K. (1998) EMBO J. 17, 6412-6425[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Moreau, S.,
Ferguson, J. R.,
and Symington, L. S.
(1999)
Mol. Cell. Biol.
19,
556-566 |
| 5. |
Hopfner, K. P.,
Karcher, A.,
Shin, D.,
Fairley, C.,
Tainer, J. A.,
and Carney, J. P.
(2000)
J. Bacteriol.
182,
6036-6041 |
| 6. |
Aravind, L.,
Walker, D. R.,
and Koonin, E. V.
(1999)
Nucleic Acids Res.
27,
1223-1242 |
| 7. | Usui, T., Ohta, T., Oshiumi, H., Tomizawa, J., Ogawa, H., and Ogawa, T. (1998) Cell 95, 705-716[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Kuzminov, A. (1995) Mol. Microbiol. 16, 373-384[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Michel, B., Ehrlich, S. D., and Uzest, M. (1997) EMBO J. 16, 430-438[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Costanzo, V., Robertson, K., Bibikova, M., Kim, E., Grieco, D., Gottesman, M., Carroll, D., and Gautier, J. (2001) Mol. Cell 8, 137-147[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Van Gent, D. C., Hoeijmakers, J. H. J., and Kanaar, R. (2001) Nat. Rev. Genet. 2, 196-206[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Haber, J. E. (1998) Annu. Rev. Genet. 32, 561-599[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Gellert, M. (1997) Adv. Immunol. 64, 39-64[Medline] [Order article via Infotrieve] |
| 14. | Johzuka, K., and Ogawa, H. (1995) Genetics 139, 1521-1532[Abstract] |
| 15. | Boulton, S. J., and Jackson, S. P. (1998) EMBO J. 17, 1819-1828[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Bressan, D. A.,
Baxter, B. K.,
and Petrini, J. H. J.
(1999)
Mol. Cell. Biol.
19,
7681-7687 |
| 17. |
Luo, G. B.,
Yao, M. S.,
Bender, C. F.,
Mills, M.,
Bladl, A. R.,
Bradley, A.,
and Petrini, J. H. J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
7376-7381 |
| 18. | Yamaguchi-Iwai, Y., Sonoda, E., Sasaki, M. S., Morrison, C., Haraguchi, T., Hiraoka, Y., Yamashita, Y. M., Yagi, T., Takata, M., Price, C., Kakazu, N., and Takeda, S. (1999) EMBO J. 18, 6619-6629[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Xiao, Y. H.,
and Weaver, D. T.
(1997)
Nucleic Acids Res.
25,
2985-2991 |
| 20. |
Tsubouchi, H.,
and Ogawa, H.
(2000)
Mol. Biol. Cell
11,
2221-2233 |
| 21. |
Chin, G. M.,
and Villeneuve, A. M.
(2001)
Genes Dev.
15,
522-534 |
| 22. | Gallego, M. E., Jeanneau, M., Granier, F., Bouchez, D., Bechtold, N., and White, C. I. (2001) Plant J. 25, 31-41[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Paull, T. T., and Gellert, M. (1998) Mol. Cell 1, 969-979[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Paull, T. T.,
and Gellert, M.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
6409-6414 |
| 25. | Maser, R. S., Monsen, K. J., Nelms, B. E., and Petrini, J. H. J. (1997) Mol. Cell. Biol. 17, 6087-6096[Abstract] |
| 26. |
Maser, R. S.,
Mirzoeva, O. K.,
Wells, J.,
Olivares, H.,
Williams, B. R.,
Zinkel, R. A.,
Farnham, P. J.,
and Petrini, J. H. J.
(2001)
Mol. Cell. Biol.
21,
6006-6016 |
| 27. |
Mirzoeva, O. K.,
and Petrini, J. H. J.
(2001)
Mol. Cell. Biol.
21,
281-288 |
| 28. | Schar, P. (2001) Cell 104, 329-332[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Myung, K. J., Datta, A., and Kolodner, R. D. (2001) Cell 104, 397-408[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Myung, K., Chen, C., and Kolodner, R. D. (2001) Nature 411, 1073-1076[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Chen, C., and Kolodner, R. D. (1999) Nat. Genet. 23, 81-85[Medline] [Order article via Infotrieve] |
| 32. | Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., and Taylor, A. M. R. (1999) Cell 99, 577-587[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le, Beau, M., Yates, J. R., Hays, L., Morgan, W. F., and Petrini, J. H. J. (1998) Cell 93, 477-486[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Kironmai, K. M., and Muniyappa, K. (1997) Genes Cells 2, 443-455[Abstract] |
| 35. | Nugent, C. I., Bosco, G., Ross, L. O., Evans, S. K., Salinger, A. P., Moore, J. K., Haber, J. E., and Lundblad, V. (1998) Curr. Biol. 8, 657-660[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Ritchie, K. B.,
and Petes, T. D.
(2000)
Genetics
155,
475-479 |
| 37. | Barry, J. D. (1997) Parasitol. Today 13, 212-218[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Borst, P., Bitter, W., Blundell, P. A., Chaves, I., Cross, M., Gerrits, H., van Leeuwen, F., McCulloch, R., Taylor, M., and Rudenko, G. (1998) Mol. Biochem. Parasitol. 91, 67-76[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Cross, G. A. M., Wirtz, L. E., and Navarro, M. (1998) Mol. Biochem. Parasitol. 91, 77-91[CrossRef][Medline] [Order article via Infotrieve] |
| 40. | Vanhamme, L., Pays, E., McCulloch, R., and Barry, J. D. (2001) Trends Parasitol. 17, 338-343[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Barry, J. D., and McCulloch, R. (2001) Adv. Parasitol. 49, 1-70[Medline] |